A detailed history of Fmr LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Fmr LLC holds 9,887,233 shares of SRRK stock, worth $286 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,887,233
Previous 10,602,377 6.75%
Holding current value
$286 Million
Previous $188 Million 56.26%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.84 - $16.79 $5.61 Million - $12 Million
-715,144 Reduced 6.75%
9,887,233 $82.4 Million
Q1 2024

May 13, 2024

BUY
$13.2 - $17.76 $2.48 Million - $3.34 Million
187,842 Added 1.8%
10,602,377 $188 Million
Q4 2023

Feb 13, 2024

BUY
$6.52 - $20.32 $15.7 Million - $48.9 Million
2,408,881 Added 30.09%
10,414,535 $196 Million
Q3 2023

Nov 13, 2023

BUY
$6.02 - $7.76 $1.75 Million - $2.26 Million
291,156 Added 3.77%
8,005,654 $56.8 Million
Q2 2023

Aug 11, 2023

BUY
$5.79 - $9.11 $2 Million - $3.15 Million
345,939 Added 4.69%
7,714,498 $58.2 Million
Q1 2023

May 11, 2023

BUY
$7.36 - $12.72 $355,134 - $613,765
48,252 Added 0.66%
7,368,559 $58.9 Million
Q4 2022

Feb 13, 2023

BUY
$7.02 - $9.76 $23,952 - $33,301
3,412 Added 0.05%
7,320,307 $66.2 Million
Q3 2022

Nov 10, 2022

BUY
$5.33 - $11.3 $10,628 - $22,532
1,994 Added 0.03%
7,316,895 $50.7 Million
Q2 2022

Aug 12, 2022

BUY
$4.66 - $13.96 $9.41 Million - $28.2 Million
2,019,396 Added 38.13%
7,314,901 $40.2 Million
Q1 2022

May 13, 2022

BUY
$11.89 - $24.68 $348,210 - $722,778
29,286 Added 0.56%
5,295,505 $68.3 Million
Q4 2021

Feb 14, 2022

BUY
$24.14 - $35.18 $2.34 Million - $3.42 Million
97,130 Added 1.88%
5,266,219 $131 Million
Q3 2021

Nov 15, 2021

BUY
$27.38 - $42.21 $185,882 - $286,563
6,789 Added 0.13%
5,169,089 $171 Million
Q2 2021

Aug 13, 2021

BUY
$26.34 - $46.62 $136 Million - $241 Million
5,162,300 New
5,162,300 $149 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.49B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.